Key result
Higher Atherogenic Index of Plasma linked to ~274% greater obstructive CAD risk in stable angina.
Why the study?
AIP is a known biochemical risk factor for CAD, but its effectiveness for estimating obstructive CAD remained to be determined.
Does the Atherogenic Index of Plasma predict obstructive coronary artery disease in patients with stable angina pectoris?
Observational (n=345)
Does the Atherogenic Index of Plasma predict obstructive coronary artery disease in patients with stable angina pectoris?
Effect estimate: OR 3.74 (95% CI 1.62-8.64)
p-value: p=0.020
The Atherogenic Index of Plasma is a significant predictor of obstructive coronary artery disease in patients with stable angina pectoris, with a cut-off value >0.49 indicating ≥50% stenosis.
AIP was associated with obstructive CAD in stable angina; leaves open its incremental predictive value pending prospective validation.
Aims: Chronic coronary syndrome is associated with several risk factors, such as dyslipidemia and hypertension. AIP has been demonstrated to be a biochemical risk factor for coronary artery disease (CAD). This study aimed to determine whether AIP is an effective parameter for estimating obstructive CAD. Methods and Results: A total of 345 patients (mean age 62,2±10,3; 63% male) who underwent coronary angiography were included in this study. Obstructive CAD is defined as having one or more vessels with a stenosis of≥50%. Depending on the presence of obstructive CAD, all patients were divided into two groups. The AIP was significantly higher in the obstructive coronary artery group (AIP; 0,49±0,26 vs. 0,58±0,27, p=0,002). In univariate analysis, AIP was significantly associated with obstructive coronary artery disease [OD:3,74 (CI95% 1,62-8,64), P=0,020]. The AIP was further adjusted for confounding risk factors in three multivariate analysis models. Therefore, all three models showed a significant association. According to ROC analysis, 0.49 is the cut-off value for AIP, and a value above 0.49 indicates 50% coronary artery stenosis Conclusions: AIP may be used in the assessment of cardiovascular risk in patients with stable angina pectoris, and it may also be used to estimate obstructive CAD.
No takes yet. Share an insight, caveat, or question.
Kürklü et al. (2023) conducted an observational in Stable Angina Pectoris (n=345). Atherogenic Index of Plasma (AIP) was evaluated on Obstructive coronary artery disease (≥50% stenosis) (OR 3.74, 95% CI 1.62-8.64, p=0.020). Higher Atherogenic Index of Plasma was significantly associated with obstructive coronary artery disease in patients with stable angina pectoris (OR 3.74; 95% CI 1.62-8.64; P=0.020).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: